Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Therapy for Pulmonary Tuberculosis
Clinical trial NCT01638520 · UNKNOWN
Trial details
- NCT number
- NCT01638520
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2017-02-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.